CN Stock MarketDetailed Quotes

300039 Shanghai Kaibao Pharmaceutical

Watchlist
  • 6.65
  • +0.03+0.45%
Market Closed Dec 20 15:00 CST
6.96BMarket Cap19.97P/E (TTM)

Shanghai Kaibao Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
110.53%1.2B
14.21%665.56M
11.83%799.69M
-13.35%601.94M
-60.42%571.46M
-56.46%582.75M
-46.91%715.12M
-48.35%694.69M
8.38%1.44B
1.53%1.34B
Transactional financial assets
-24.97%120.44M
253.30%116.18M
27.20%118.8M
10.24%150.01M
1.18%160.52M
-69.71%32.89M
-19.46%93.39M
165.45%136.07M
130.24%158.65M
19.01%108.57M
Notes receivable and accounts receivable
-13.66%439.89M
-16.98%526.06M
-12.39%566.23M
-0.19%529.32M
-3.48%509.51M
22.89%633.63M
3.00%646.29M
-6.63%530.33M
3.90%527.88M
-0.59%515.62M
-Notes receivable
-31.18%153.31M
-27.76%208.57M
-14.50%217.75M
2.13%158.96M
4.85%222.77M
41.15%288.71M
4.03%254.7M
-29.76%155.65M
13.86%212.46M
4.26%204.53M
-Accounts receivable
-0.05%286.58M
-7.96%317.48M
-11.01%348.48M
-1.15%370.36M
-9.10%286.73M
10.88%344.93M
2.34%391.59M
8.17%374.68M
-1.88%315.42M
-3.55%311.09M
Other receivables (including interest and dividends)
-99.08%526.39K
-98.82%346K
-49.52%12.54M
-98.84%414.42K
-1.79%56.99M
-55.02%29.31M
-56.64%24.85M
-23.53%35.77M
18.48%58.03M
37.36%65.16M
-Accrued interest receivable
----
----
----
----
-29.26%36.73M
-54.53%26.72M
-58.86%21.49M
-23.82%34.84M
21.25%51.92M
51.50%58.75M
-Other receivable
----
-86.65%346K
----
----
----
-59.54%2.59M
----
-10.78%926.6K
----
-25.99%6.41M
Advance payment
-38.24%16.45M
106.06%68.97M
-63.79%5.93M
-47.34%6.81M
250.10%26.64M
36.61%33.47M
263.66%16.37M
29.84%12.93M
-83.67%7.61M
-41.12%24.5M
Inventories
13.51%188.41M
-0.43%151.72M
1.63%159.19M
6.84%171.79M
2.93%165.98M
-3.19%152.37M
-4.86%156.64M
-2.63%160.8M
-16.24%161.26M
-20.04%157.39M
Non-current assets due within one year
----
----
----
----
----
----
----
----
----
185.23%58.32M
Other current assets
215.32%45.71M
299.24%26.03M
223.00%17.88M
279.90%14.59M
15,194.64%14.5M
-49.01%6.52M
-53.33%5.54M
-61.71%3.84M
-99.12%94.79K
1,579.45%12.79M
Total current assets
33.80%2.01B
5.71%1.55B
1.33%1.68B
-6.32%1.47B
-36.13%1.51B
-35.51%1.47B
-30.53%1.66B
-30.16%1.57B
6.77%2.36B
2.04%2.28B
Non Current assets
Other equity investment
-21.37%920.64M
-54.39%603.69M
-45.54%860.09M
0.36%1.26B
-13.77%1.17B
-41.01%1.32B
98.27%1.58B
87.92%1.26B
118.51%1.36B
804.04%2.24B
Other non-current financial assets
3.93%47.89M
3.93%47.89M
3.93%47.89M
3.93%47.89M
9.77%46.07M
9.77%46.07M
9.77%46.07M
9.77%46.07M
34.95%41.97M
89.90%41.97M
Long-term equity investment
----
----
----
----
-58.26%7.25M
-58.26%7.25M
-51.56%8.41M
--8.41M
--17.37M
--17.37M
Fixed assets
----
-3.28%276.44M
----
----
----
10.79%285.81M
----
9.08%298.49M
----
-7.42%257.98M
Constru in process
----
-94.40%884.02K
----
----
----
-65.44%15.77M
----
-81.91%6.18M
----
572.35%45.64M
Intangible assets
285.85%170.15M
281.57%171.45M
2.15%44.39M
1.99%45.11M
7.15%44.1M
7.65%44.93M
2.69%43.46M
3.09%44.23M
-5.99%41.15M
-5.66%41.74M
Goodwill
----
----
----
----
-34.46%9.04M
-34.46%9.04M
-34.46%9.04M
-34.46%9.04M
-25.44%13.79M
-25.44%13.79M
Long deferred expense
384.78%1.83M
419.53%1.67M
-28.12%212.16K
-34.29%212.16K
--376.99K
--321.64K
--295.18K
--322.86K
----
----
Deferred tax assets
74.46%27.87M
39.14%25.19M
77.74%32.67M
73.08%31.61M
-5.14%15.98M
17.12%18.1M
18.71%18.38M
20.93%18.26M
-4.25%16.84M
-13.34%15.46M
Other non current assets
-33.16%874.64M
-1.48%1.29B
22.43%1.34B
43.31%1.43B
--1.31B
--1.31B
12,829.63%1.09B
9,165.66%996.49M
----
----
Total non current assets
-20.15%2.31B
-21.02%2.42B
-15.90%2.61B
15.64%3.1B
60.98%2.9B
14.24%3.06B
150.91%3.1B
143.77%2.68B
67.07%1.8B
298.28%2.68B
Total assets
-1.70%4.33B
-12.34%3.97B
-9.89%4.29B
7.52%4.58B
5.91%4.4B
-8.64%4.53B
31.34%4.76B
26.92%4.26B
26.54%4.16B
70.53%4.96B
Liabilities
Current liabilities
Short term loan
--2.99M
----
----
----
----
----
----
----
----
----
Notes payable and accounts payable
91.47%218.99M
26.36%229.97M
23.45%197.23M
48.17%134.85M
39.64%114.38M
198.12%182M
34.29%159.77M
21.32%91.01M
13.03%81.91M
-22.68%61.05M
-Accounts payable
91.47%218.99M
26.36%229.97M
23.45%197.23M
48.17%134.85M
39.64%114.38M
198.12%182M
34.29%159.77M
21.32%91.01M
13.03%81.91M
-22.68%61.05M
Contract liabilities
2.20%18.97M
-39.91%15.58M
13.03%28.18M
14.10%45.69M
18.74%18.56M
7,829.67%25.93M
1,070.30%24.93M
1,289.74%40.04M
939.97%15.63M
-66.19%327.03K
Salaries payable
72.36%7.11M
68.12%7.37M
8.37%1.04M
148.97%1.96M
72.07%4.12M
123.54%4.38M
-22.66%960.67K
-59.15%788.02K
-48.71%2.4M
-49.98%1.96M
Taxs payable
-44.96%18.98M
-6.97%19.87M
32.35%40.52M
-3.54%61.34M
11.45%34.48M
7.45%21.35M
-2.36%30.61M
288.70%63.59M
81.90%30.94M
36.27%19.87M
Other payable (including interest and dividends)
-77.56%45.43M
-59.86%71.3M
-48.65%87.33M
-6.42%82.62M
95.12%202.49M
65.12%177.64M
52.59%170.06M
2.16%88.29M
8.47%103.78M
-11.61%107.58M
-Other payable
----
-59.86%71.3M
----
----
----
65.12%177.64M
----
2.16%88.29M
----
-11.61%107.58M
Other current liabilities
-63.95%4.19M
-65.76%5.96M
-57.60%3.1M
-31.45%8.39M
85.97%11.64M
--17.4M
-18.25%7.31M
51.63%12.24M
3,101.65%6.26M
----
Total current liabilities
-17.89%316.66M
-18.35%350.05M
-9.21%357.39M
13.14%334.85M
60.09%385.66M
124.70%428.7M
43.62%393.63M
55.21%295.96M
25.79%240.91M
-13.33%190.79M
Current liabilities
Deferred tax liabilities
-21.49%117.53M
-59.46%69.99M
-48.62%108.45M
3.65%168.71M
-15.11%149.7M
-44.17%172.65M
128.98%211.07M
122.79%162.77M
1,685.04%176.35M
3,030.36%309.26M
Long term deferred income
-14.58%38.7M
6.36%40.11M
8.87%41.46M
9.49%43.26M
3.66%45.31M
-16.48%37.71M
-16.64%38.08M
-16.23%39.51M
-9.15%43.71M
-7.72%45.16M
Total non current liabilities
-19.89%156.23M
-47.66%110.1M
-39.83%149.9M
4.79%211.97M
-11.38%195.01M
-40.64%210.37M
80.73%249.15M
68.25%202.28M
279.47%220.06M
502.61%354.41M
Total liabilities
-18.56%472.89M
-28.00%460.15M
-21.08%507.29M
9.75%546.82M
25.97%580.67M
17.22%639.07M
56.04%642.78M
60.25%498.24M
84.75%460.97M
95.45%545.21M
Shareholders equity
Paid-in capital
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
0.00%1.05B
Capital reserve funds
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
0.00%8.62M
Surplus reserve funds
16.09%252.36M
16.09%252.37M
16.09%252.37M
16.09%252.37M
13.35%217.39M
13.35%217.39M
13.35%217.39M
13.35%217.39M
5.87%191.79M
5.87%191.79M
Retained profit
12.30%1.91B
11.90%1.84B
14.47%1.89B
14.68%1.8B
17.21%1.7B
15.88%1.64B
14.23%1.65B
13.20%1.57B
5.86%1.45B
5.85%1.42B
Other composite income
-25.00%636.33M
-62.49%366.93M
-51.08%584.87M
0.47%926.33M
-15.06%848.41M
-44.17%978.22M
129.11%1.2B
122.95%921.98M
132.93%998.84M
3,046.80%1.75B
Shareholders equity without minority interests
0.84%3.85B
-9.80%3.51B
-8.20%3.78B
7.16%4.03B
3.38%3.82B
-11.86%3.89B
28.18%4.12B
23.54%3.76B
21.77%3.7B
67.91%4.41B
Minority interests
279.18%1.21M
248.36%1.4M
288.96%1.48M
326.98%1.64M
155.84%318.65K
179.56%402.82K
-57.82%-782.78K
-31,053.27%-722.05K
---570.69K
---506.33K
Total shareholder equity
0.86%3.85B
-9.77%3.51B
-8.15%3.78B
7.23%4.03B
3.41%3.82B
-11.84%3.89B
28.17%4.11B
23.52%3.76B
21.75%3.7B
67.89%4.41B
Total liabilityies and equity
-1.70%4.33B
-12.34%3.97B
-9.89%4.29B
7.52%4.58B
5.91%4.4B
-8.64%4.53B
31.34%4.76B
26.92%4.26B
26.54%4.16B
70.53%4.96B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 110.53%1.2B14.21%665.56M11.83%799.69M-13.35%601.94M-60.42%571.46M-56.46%582.75M-46.91%715.12M-48.35%694.69M8.38%1.44B1.53%1.34B
Transactional financial assets -24.97%120.44M253.30%116.18M27.20%118.8M10.24%150.01M1.18%160.52M-69.71%32.89M-19.46%93.39M165.45%136.07M130.24%158.65M19.01%108.57M
Notes receivable and accounts receivable -13.66%439.89M-16.98%526.06M-12.39%566.23M-0.19%529.32M-3.48%509.51M22.89%633.63M3.00%646.29M-6.63%530.33M3.90%527.88M-0.59%515.62M
-Notes receivable -31.18%153.31M-27.76%208.57M-14.50%217.75M2.13%158.96M4.85%222.77M41.15%288.71M4.03%254.7M-29.76%155.65M13.86%212.46M4.26%204.53M
-Accounts receivable -0.05%286.58M-7.96%317.48M-11.01%348.48M-1.15%370.36M-9.10%286.73M10.88%344.93M2.34%391.59M8.17%374.68M-1.88%315.42M-3.55%311.09M
Other receivables (including interest and dividends) -99.08%526.39K-98.82%346K-49.52%12.54M-98.84%414.42K-1.79%56.99M-55.02%29.31M-56.64%24.85M-23.53%35.77M18.48%58.03M37.36%65.16M
-Accrued interest receivable -----------------29.26%36.73M-54.53%26.72M-58.86%21.49M-23.82%34.84M21.25%51.92M51.50%58.75M
-Other receivable -----86.65%346K-------------59.54%2.59M-----10.78%926.6K-----25.99%6.41M
Advance payment -38.24%16.45M106.06%68.97M-63.79%5.93M-47.34%6.81M250.10%26.64M36.61%33.47M263.66%16.37M29.84%12.93M-83.67%7.61M-41.12%24.5M
Inventories 13.51%188.41M-0.43%151.72M1.63%159.19M6.84%171.79M2.93%165.98M-3.19%152.37M-4.86%156.64M-2.63%160.8M-16.24%161.26M-20.04%157.39M
Non-current assets due within one year ------------------------------------185.23%58.32M
Other current assets 215.32%45.71M299.24%26.03M223.00%17.88M279.90%14.59M15,194.64%14.5M-49.01%6.52M-53.33%5.54M-61.71%3.84M-99.12%94.79K1,579.45%12.79M
Total current assets 33.80%2.01B5.71%1.55B1.33%1.68B-6.32%1.47B-36.13%1.51B-35.51%1.47B-30.53%1.66B-30.16%1.57B6.77%2.36B2.04%2.28B
Non Current assets
Other equity investment -21.37%920.64M-54.39%603.69M-45.54%860.09M0.36%1.26B-13.77%1.17B-41.01%1.32B98.27%1.58B87.92%1.26B118.51%1.36B804.04%2.24B
Other non-current financial assets 3.93%47.89M3.93%47.89M3.93%47.89M3.93%47.89M9.77%46.07M9.77%46.07M9.77%46.07M9.77%46.07M34.95%41.97M89.90%41.97M
Long-term equity investment -----------------58.26%7.25M-58.26%7.25M-51.56%8.41M--8.41M--17.37M--17.37M
Fixed assets -----3.28%276.44M------------10.79%285.81M----9.08%298.49M-----7.42%257.98M
Constru in process -----94.40%884.02K-------------65.44%15.77M-----81.91%6.18M----572.35%45.64M
Intangible assets 285.85%170.15M281.57%171.45M2.15%44.39M1.99%45.11M7.15%44.1M7.65%44.93M2.69%43.46M3.09%44.23M-5.99%41.15M-5.66%41.74M
Goodwill -----------------34.46%9.04M-34.46%9.04M-34.46%9.04M-34.46%9.04M-25.44%13.79M-25.44%13.79M
Long deferred expense 384.78%1.83M419.53%1.67M-28.12%212.16K-34.29%212.16K--376.99K--321.64K--295.18K--322.86K--------
Deferred tax assets 74.46%27.87M39.14%25.19M77.74%32.67M73.08%31.61M-5.14%15.98M17.12%18.1M18.71%18.38M20.93%18.26M-4.25%16.84M-13.34%15.46M
Other non current assets -33.16%874.64M-1.48%1.29B22.43%1.34B43.31%1.43B--1.31B--1.31B12,829.63%1.09B9,165.66%996.49M--------
Total non current assets -20.15%2.31B-21.02%2.42B-15.90%2.61B15.64%3.1B60.98%2.9B14.24%3.06B150.91%3.1B143.77%2.68B67.07%1.8B298.28%2.68B
Total assets -1.70%4.33B-12.34%3.97B-9.89%4.29B7.52%4.58B5.91%4.4B-8.64%4.53B31.34%4.76B26.92%4.26B26.54%4.16B70.53%4.96B
Liabilities
Current liabilities
Short term loan --2.99M------------------------------------
Notes payable and accounts payable 91.47%218.99M26.36%229.97M23.45%197.23M48.17%134.85M39.64%114.38M198.12%182M34.29%159.77M21.32%91.01M13.03%81.91M-22.68%61.05M
-Accounts payable 91.47%218.99M26.36%229.97M23.45%197.23M48.17%134.85M39.64%114.38M198.12%182M34.29%159.77M21.32%91.01M13.03%81.91M-22.68%61.05M
Contract liabilities 2.20%18.97M-39.91%15.58M13.03%28.18M14.10%45.69M18.74%18.56M7,829.67%25.93M1,070.30%24.93M1,289.74%40.04M939.97%15.63M-66.19%327.03K
Salaries payable 72.36%7.11M68.12%7.37M8.37%1.04M148.97%1.96M72.07%4.12M123.54%4.38M-22.66%960.67K-59.15%788.02K-48.71%2.4M-49.98%1.96M
Taxs payable -44.96%18.98M-6.97%19.87M32.35%40.52M-3.54%61.34M11.45%34.48M7.45%21.35M-2.36%30.61M288.70%63.59M81.90%30.94M36.27%19.87M
Other payable (including interest and dividends) -77.56%45.43M-59.86%71.3M-48.65%87.33M-6.42%82.62M95.12%202.49M65.12%177.64M52.59%170.06M2.16%88.29M8.47%103.78M-11.61%107.58M
-Other payable -----59.86%71.3M------------65.12%177.64M----2.16%88.29M-----11.61%107.58M
Other current liabilities -63.95%4.19M-65.76%5.96M-57.60%3.1M-31.45%8.39M85.97%11.64M--17.4M-18.25%7.31M51.63%12.24M3,101.65%6.26M----
Total current liabilities -17.89%316.66M-18.35%350.05M-9.21%357.39M13.14%334.85M60.09%385.66M124.70%428.7M43.62%393.63M55.21%295.96M25.79%240.91M-13.33%190.79M
Current liabilities
Deferred tax liabilities -21.49%117.53M-59.46%69.99M-48.62%108.45M3.65%168.71M-15.11%149.7M-44.17%172.65M128.98%211.07M122.79%162.77M1,685.04%176.35M3,030.36%309.26M
Long term deferred income -14.58%38.7M6.36%40.11M8.87%41.46M9.49%43.26M3.66%45.31M-16.48%37.71M-16.64%38.08M-16.23%39.51M-9.15%43.71M-7.72%45.16M
Total non current liabilities -19.89%156.23M-47.66%110.1M-39.83%149.9M4.79%211.97M-11.38%195.01M-40.64%210.37M80.73%249.15M68.25%202.28M279.47%220.06M502.61%354.41M
Total liabilities -18.56%472.89M-28.00%460.15M-21.08%507.29M9.75%546.82M25.97%580.67M17.22%639.07M56.04%642.78M60.25%498.24M84.75%460.97M95.45%545.21M
Shareholders equity
Paid-in capital 0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B0.00%1.05B
Capital reserve funds 0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M0.00%8.62M
Surplus reserve funds 16.09%252.36M16.09%252.37M16.09%252.37M16.09%252.37M13.35%217.39M13.35%217.39M13.35%217.39M13.35%217.39M5.87%191.79M5.87%191.79M
Retained profit 12.30%1.91B11.90%1.84B14.47%1.89B14.68%1.8B17.21%1.7B15.88%1.64B14.23%1.65B13.20%1.57B5.86%1.45B5.85%1.42B
Other composite income -25.00%636.33M-62.49%366.93M-51.08%584.87M0.47%926.33M-15.06%848.41M-44.17%978.22M129.11%1.2B122.95%921.98M132.93%998.84M3,046.80%1.75B
Shareholders equity without minority interests 0.84%3.85B-9.80%3.51B-8.20%3.78B7.16%4.03B3.38%3.82B-11.86%3.89B28.18%4.12B23.54%3.76B21.77%3.7B67.91%4.41B
Minority interests 279.18%1.21M248.36%1.4M288.96%1.48M326.98%1.64M155.84%318.65K179.56%402.82K-57.82%-782.78K-31,053.27%-722.05K---570.69K---506.33K
Total shareholder equity 0.86%3.85B-9.77%3.51B-8.15%3.78B7.23%4.03B3.41%3.82B-11.84%3.89B28.17%4.11B23.52%3.76B21.75%3.7B67.89%4.41B
Total liabilityies and equity -1.70%4.33B-12.34%3.97B-9.89%4.29B7.52%4.58B5.91%4.4B-8.64%4.53B31.34%4.76B26.92%4.26B26.54%4.16B70.53%4.96B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday+1.17%
Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+0.82%
Bird Flu
Bird Flu
Intraday+0.81%